AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM
Report
- Report Number
- 1018233-2008-00019
- Event Type
- Injury
- Date Received
- March 24, 2008
- Date of Event
- February 29, 2008
- Report Date
- March 28, 2008
- Manufacturer
- C.R. BARD, INC.
- Product Code
- FTL
- PMA / PMN Number
- K063712
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- PHYSICIAN
Narratives
THE LOT NUMBER IS UNK THEREFORE, NO REVIEW OF THE DEVICE HISTORY RECORD COULD BE PERFORMED. THE INSTRUCTIONS FOR USE STATES THAT INFECTION IS A WELL KNOWN POTENTIAL COMPLICATION OF THIS TYPE OF PROCEDURE. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES EACH DEVICE STATES IN THE SECTION LABELED ADVERSE REACTIONS THAT POTENTIAL ADVERSE REACTIONS ARE THOSE TYPICALLY ASSOCIATED WITH SURGICALLY IMPLANTABLE MATERIALS, INCLUDING HEMATOMA, SEROMA, MUCOSAL OR VISCERAL EROSION, INFECTION, INFLAMMATION, SENSITIZATION, DYSPAREUNIA, SCARIFICATION AND CONTRACTION, FISTULA FORMATION, EXTRUSION AND RECURRENCE OF VAGINAL WALL PROLAPSE. PERFORATIONS OR LACERATIONS OF VESSELS, NERVES, BLADDER, BOWEL, RECTUM, OR ANY VISCERA MAY OCCUR DURING NEEDLE PASSAGE. THE PRODUCT IS RECOMMENDED TO ONLY BE USED BY PHYSICIANS WHO ARE TRAINED IN SURGICAL PROCEDURES AND TECHNIQUES REQUIRED FOR PELVIC FLOOR RECONSTRUCTION AND THE IMPLANTATION OF NONABSORBABLE MESHES. BASELINE REPORT PREVIOUSLY FILED.
IT WAS REPORTED THAT THE PT EXPERIENCED THREE ABSCESSES FOLLOWING A PELVIC RECONSTRUCTION PROCEDURE IN 2007. THE ABSCESSES WERE DESCRIBED AS STERILE ABSCESSES WITH PUS AND DRAINAGE. THE LOCATIONS OF THE ABSCESSES WERE DESCRIBED AS TWO AT THE DISTAL ARMS TO THE INTROITUS, AND ONE AT THE PROXIMAL ARM ON THE PT'S RIGHT SIDE. THE PT WAS TREATED WITH ANTIBIOTICS. THE DOCTOR REMOVED THE IMPLANT IN 2008, AND SENT THE REMOVED IMPLANT MATERIAL TO HOSPITAL PATHOLOGY. ADD'L INFO HAS BEEN REQUESTED BUT NOT YET RECEIVED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | AVAULTA PLUS BIOSYNTHETIC SUPPORT SYSTEM | FTL | C.R. BARD, INC. | NA | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 66 YR | Required Intervention |